BusinessCascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXApr 5, 2017, 12:00 PM UTC
BusinessOncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 8, 2017, 9:06 PM UTC
BusinessOncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 8, 2017, 9:06 PM UTC
BusinessOncoMed Announces Multiple Abstracts Related to Anti-TIGIT Program Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXMar 2, 2017, 1:31 PM UTC
BusinessOncoMed Announces Multiple Abstracts Related to Anti-TIGIT Program Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXMar 2, 2017, 1:31 PM UTC
BusinessOncoMed Announces Year-End Cash Balance and 2017 OutlookBy Nasdaq OMXJan 5, 2017, 1:31 PM UTC
BusinessOncoMed Announces Year-End Cash Balance and 2017 OutlookBy Nasdaq OMXJan 5, 2017, 1:31 PM UTC
